SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has demonstrated the value of pursuing different vaccine strategies. Vaccines based on whole viruses, a widely used vaccine technology, depend on efficient virus production. This study aimed to establish SARS-CoV-2 production...

Descripción completa

Detalles Bibliográficos
Autores principales: Offersgaard, Anna, Duarte Hernandez, Carlos Rene, Pihl, Anne Finne, Costa, Rui, Venkatesan, Nandini Prabhakar, Lin, Xiangliang, Van Pham, Long, Feng, Shan, Fahnøe, Ulrik, Scheel, Troels Kasper Høyer, Ramirez, Santseharay, Reichl, Udo, Bukh, Jens, Genzel, Yvonne, Gottwein, Judith Margarete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310283/
https://www.ncbi.nlm.nih.gov/pubmed/34209694
http://dx.doi.org/10.3390/vaccines9070706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310283/
https://www.ncbi.nlm.nih.gov/pubmed/34209694
http://dx.doi.org/10.3390/vaccines9070706

Ejemplares similares